Table 10.
Univariate and multivariate influences on PFS.
| Variable | Univariate | Multivariate 1 | Multivariate 2 | Multivariate 3 |
|---|---|---|---|---|
| Age | ||||
| HR | 1.014 | |||
| 95% CI | 0.976–1.054 | |||
| p | 0.470 | |||
| Female Sex | ||||
| HR | 0.526 | |||
| 95% CI | 0.2–1.385 | |||
| p | 0.193 | |||
| LDH | ||||
| HR | 1.007 | 1.005 | 1.007 | |
| 95% CI | 1.003–1.010 | 1.001–1.009 | 1.003–1.010 | |
| p | 0.000 | 0.007 | 0.000 | |
| Bcl-2 negative | ||||
| HR | 0.63 | |||
| 95% CI | 0.195–2.044 | |||
| p | 0.442 | |||
| Bcl-6 negative | ||||
| HR | 0.883 | |||
| 95% CI | 0.276–2.831 | |||
| p | 0.834 | |||
| No Extranodal disease | ||||
| HR | 0.283 | 0.644 | ||
| 95% CI | 0.112–0.719 | 0.180–2.310 | ||
| p | 0.008 | 0.500 | ||
| FLIPI | ||||
| HR | 2.428 | 2.422 | ||
| 95% CI | 1.365–4.318 | 1.302–4.513 | ||
| p | 0.003 | 0.005 | ||
| Deauville Score | ||||
| HR | 1.18 | 0.974 | 1.103 | |
| 95% CI | 0.821–1.687 | 0.666–1.425 | 0.750–1.621 | |
| p | 0.376 | 0.892 | 0.619 | |
| Stage I/II | ||||
| HR | 0.194 | 0.248 | ||
| 95% CI | 0.069–0.547 | 0.045–1.367 | ||
| p | 0.002 | 0.110 |